Myriad Genetics, Inc. (MYGN)
4.29
+0.20
(+4.89%)
USD |
NASDAQ |
May 08, 16:00
4.285
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Market Cap : 405.18M for May 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Celldex Therapeutics, Inc. | 2.662B |
| Plus Therapeutics, Inc. | 42.00M |
| Perspective Therapeutics, Inc. | 428.39M |
| Atossa Therapeutics, Inc. | 48.22M |
| AVITA Medical, Inc. | 125.90M |
Market Cap Related Metrics
| PS Ratio | 0.482 |
| PEG Ratio | -0.0035 |
| Price to Book Value | 1.201 |
| Price | 4.29 |
| Earnings Yield | -100.6% |
| PEGY Ratio | -0.0035 |